Urology
Volume 72, Issue 6 , Pages 1302-1303 , December 2008

Editorial Comment

References 

  1. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572–578
  2. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA. 2006;296:2329–2335
  3. Wiegel T, Bottke D, Willich N, et al. Phase III trial results of adjuvant radiotherapy (RT) versus “wait and see” (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 9602/AUO AP 09/95). J Clin Oncol. 2005;23:16s
  4. Nahum AE, Movsas B, Horwitz EM, et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys. 2003;57:391–401

PII: S0090-4295(08)00768-1

doi: 10.1016/j.urology.2008.06.022

Urology
Volume 72, Issue 6 , Pages 1302-1303 , December 2008

Article Tools